E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer
Public ClinicalTrials.gov record NCT00388726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
The "EMBRACE" Trial: Eisai Metastatic Breast Cancer Study Assessing Physician's Choice Versus E7389. A Phase III Open-Label, Randomized, Parallel, Two-arm, Multi-center Study of E7389 Versus "Treatment of Physician's Choice" in Patients With Locally Recurrent, Metastatic Breast Cancer, Previously Treated With At Least Two and a Maximum of Five Prior Chemotherapy Regimens, Including an Anthracycline and a Taxane
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to compare Overall Survival (OS), Progression Free Survival (PFS), objective tumor response rate, duration of response, and safety in patients treated with E7389 versus the Treatment of Physician's Choice (TPC) in patients with locally recurrent or metastatic breast cancer.
Study identification
- NCT ID
- NCT00388726
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 762 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2006
- Primary completion
- Apr 30, 2009
- Completion
- May 31, 2013
- Last update posted
- Jan 6, 2020
2006 – 2013
United States locations
- U.S. sites
- 32
- U.S. states
- 18
- U.S. cities
- 32
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| US Oncology St. Vincent's Hospital - Bruno Cancer Center | Birmingham | Alabama | — | — |
| Bellflower Satellite | Bellflower | California | — | — |
| Research Center | Gilroy | California | 95020 | — |
| US Oncology | Denver | Colorado | — | — |
| Florida Cancer Research Institute | Davie | Florida | — | — |
| Innovative Medical Research of South Florida, Inc. | Miami | Florida | 33179 | — |
| Peachtree Hematology/Oncology Consultants, PC | Atlanta | Georgia | — | — |
| US Oncology | Niles | Illinois | — | — |
| US Oncology | Indianapolis | Indiana | — | — |
| University of Iowa Hospital and Clinic | Iowa City | Iowa | — | — |
| Hematology Oncology Clinic | Baton Rouge | Louisiana | — | — |
| Oncology Care Associates, P.L.L.C. | Saint Joseph | Michigan | — | — |
| US Oncology | Columbia | Missouri | — | — |
| Montana Cancer Specialists | Missoula | Montana | 59820 | — |
| US Oncology | Las Vegas | Nevada | — | — |
| US Oncology | Albany | New York | — | — |
| North Shore Hematology/Oncology Associates | East Setauket | New York | — | — |
| Weill Cornell Breast Cancer Center | New York | New York | — | — |
| Carolina Hematology Oncology Associates | Charlotte | North Carolina | — | — |
| US Oncology | Raleigh | North Carolina | — | — |
| US Oncology | Eugene | Oregon | — | — |
| St. Vincent Medical Center | Portland | Oregon | — | — |
| US Oncology | Bedford | Texas | — | — |
| US Oncology | Dallas | Texas | — | — |
| US Oncology | Houston | Texas | — | — |
| US Oncology | McAllen | Texas | — | — |
| US Oncology | Midland | Texas | — | — |
| US Oncology | Tyler | Texas | — | — |
| US Oncology | Spokane | Washington | — | — |
| Northwest Medical Specialists | Tacoma | Washington | 98401 | — |
| US Oncology | Vancouver | Washington | — | — |
| US Oncology | Yakima | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 105 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00388726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 6, 2020 · Synced Sep 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00388726 live on ClinicalTrials.gov.